Fragile X syndrome

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nature Reviews Disease Primers

• Publication date

  2017-09-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nrdp.2017.65PMID 28960184
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metformin as targeted treatment in fragile X syndrome

  2018cited by this paper
• Human pluripotent stem cells in modeling human disorders: the case of fragile X syndrome.

  2017cited by this paper
• Language Skills of Males with Fragile X Syndrome or Nonsyndromic Autism Spectrum Disorder

  2017cited by this paper
• Intragenic FMR1 disease-causing variants: a significant mutational mechanism leading to Fragile-X syndrome

  2017cited by this paper
• Arbaclofen in fragile X syndrome: results of phase 3 trials

  2017cited by this paper
• Updated report on tools to measure outcomes of clinical trials in fragile X syndrome

  2017cited by this paper
• Phenolics from Mikania micrantha and Their Antioxidant Activity

  2017cited by this paper
• A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome

  2017cited by this paper
• Impaired GABAergic inhibition in the hippocampus of Fmr1 knockout mice

  2017cited by this paper
• Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment

  2017cited by this paper
• White matter microstructure, cognition, and molecular markers in fragile X premutation females

  2017cited by this paper
• FORWARD: A Registry and Longitudinal Clinical Database to Study Fragile X Syndrome

  2017cited by this paper
• Metformin ameliorates core deficits in a mouse model of fragile X syndrome

  2017cited by this paper
• Deficits in the activity of presynaptic γ-aminobutyric acid type B receptors contribute to altered neuronal excitability in fragile X syndrome

  2017cited by this paper
• Retracted: Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566

  2017cited by this paper
• Autism Spectrum Disorder Symptoms in Infants with Fragile X Syndrome: A Prospective Case Series

  2017cited by this paper
• Molecular analyses of neurogenic defects in a human pluripotent stem cell model of fragile X syndrome

  2017cited by this paper
• Abnormal trajectories in cerebellum and brainstem volumes in carriers of the fragile X premutation.

  2017cited by this paper
• Increased Persistent Sodium Current Causes Neuronal Hyperexcitability in the Entorhinal Cortex of Fmr1 Knockout Mice.

  2016cited by this paper
• Fragile X Mental Retardation Protein (FMRP) controls diacylglycerol kinase activity in neurons

  2016cited by this paper
• Elevated ERK/p90 ribosomal S6 kinase activity underlies audiogenic seizure susceptibility in fragile X mice

  2016cited by this paper
• The NIH Toolbox Cognitive Battery for intellectual disabilities: three preliminary studies and future directions

  2016cited by this paper
• Contraction of fully expanded FMR1 alleles to the normal range: predisposing haplotype or rare events?

  2016cited by this paper
• FXTAS, FXPOI, and Other Premutation Disorders

  2016cited by this paper
• Clinical Potential of Neurosteroids for CNS Disorders.

  2016cited by this paper
• Augmented noncanonical BMP type II receptor signaling mediates the synaptic abnormality of fragile X syndrome

  2016cited by this paper
• Abnormal Mechanisms of Plasticity and Metaplasticity in Autism Spectrum Disorders and Fragile X Syndrome

  2016cited by this paper
• A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome

  2016cited by this paper
• Insulin Signaling Misregulation underlies Circadian and Cognitive Deficits in a Drosophila Fragile X Model

  2016cited by this paper
• Fragile X Syndrome Diagnosis Treatment And Research

  2016cited by this paper
• Molecular Correlates and Recent Advancements in the Diagnosis and Screening of FMR1-Related Disorders

  2016cited by this paper
• Aggression in fragile X syndrome.

  2016cited by this paper
• Fragile X-associated tremor/ataxia syndrome — features, mechanisms and management

  2016cited by this paper
• A Spoken-Language Intervention for School-Aged Boys With Fragile X Syndrome.

  2016cited by this paper
• Lovastatin corrects ERK pathway hyperactivation in fragile X syndrome: potential of platelet’s signaling cascades as new outcome measures in clinical trials

  2016cited by this paper
• Early Language Intervention Using Distance Video-Teleconferencing: A Pilot Study of Young Boys With Fragile X Syndrome and Their Mothers.

  2016cited by this paper
• Social/economic costs and health-related quality of life in patients with fragile X syndrome in Europe

  2016cited by this paper
• Altered Brain Network Segregation in Fragile X Syndrome Revealed by Structural Connectomics

  2016cited by this paper
• Family Communication and Cascade Testing for Fragile X Syndrome

  2016cited by this paper
• Caregiver Preferences for the Treatment of Males with Fragile X Syndrome

  2016cited by this paper
• Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials

  2016cited by this paper
• Trajectory and Predictors of Depression and Anxiety Disorders in Mothers With the FMR1 Premutation.

  2016cited by this paper
• Chapter 20 – Fragile X Syndrome

  2016cited by this paper
• Hypothalamic-pituitary-adrenal axis function in Fragile X Syndrome and its relationship to behaviour: A systematic review.

  2016cited by this paper
• Profiles of aberrant white matter microstructure in fragile X syndrome

  2016cited by this paper
• Somatosensory attention identifies both overt and covert awareness in disorders of consciousness

  2016cited by this paper
• Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizures

  2015cited by this paper
• Examining the neural correlates of emergent equivalence relations in fragile X syndrome.

  2015cited by this paper
• Dysregulation and restoration of translational homeostasis in fragile X syndrome

  2015cited by this paper
• Mutsβ generates both expansions and contractions in a mouse model of the Fragile X-associated disorders.

  2015cited by this paper
• Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons.

  2015cited by this paper
• Increased expression of the PI3K enhancer PIKE mediates deficits in synaptic plasticity and behavior in fragile X syndrome.

  2015cited by this paper
• The GABAA receptor is an FMRP target with therapeutic potential in fragile X syndrome

  2015cited by this paper
• Advanced technologies for the molecular diagnosis of fragile X syndrome

  2015cited by this paper
• Fmr1 deficiency promotes age-dependent alterations in the cortical synaptic proteome

  2015cited by this paper
• Positron Emission Tomography (PET) Quantification of GABAA Receptors in the Brain of Fragile X Patients

  2015cited by this paper
• NNZ-2566, a Novel Analog of (1–3) IGF-1, as a Potential Therapeutic Agent for Fragile X Syndrome

  2015cited by this paper
• Molecular Diagnosis of Fragile X Syndrome in Subjects with Intellectual Disability of Unknown Origin: Implications of Its Prevalence in Regional Pakistan

  2015cited by this paper
• Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to Synaptic Deficits in Fragile X Syndrome.

  2015cited by this paper
• Fmrp Interacts with Adar and Regulates RNA Editing, Synaptic Density and Locomotor Activity in Zebrafish

  2015cited by this paper
• Symptoms of Autism in Males with Fragile X Syndrome: A Comparison to Nonsyndromic ASD Using Current ADI-R Scores

  2015cited by this paper
• Placebo Responses in Genetically Determined Intellectual Disability: A Meta-Analysis

  2015cited by this paper
• Insights into GABAAergic system deficits in fragile X syndrome lead to clinical trials.

  2015cited by this paper
• Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back

  2015cited by this paper
• Expression of fragile X mental retardation protein in neurons and glia of the developing and adult mouse brain.

  2015cited by this paper
• A 6-Week, Randomized, Multicenter, Double-Blind, Parallel, Flexed- and Fixed-Dose Study of MDX (Metadoxine Extended-Release; MG01CI) Compared With Placebo in Adolescents and Adults With Fragile X Syndrome

  2015cited by this paper
• The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders.

  2015cited by this paper
• Fragile X syndrome: economic burden and health-related quality of life of patients and caregivers in France.

  2015cited by this paper
• Altered Neuronal and Circuit Excitability in Fragile X Syndrome.

  2015cited by this paper
• Improving IQ measurement in intellectual disabilities using true deviation from population norms

  2014cited by this paper
• Promoter-Bound Trinucleotide Repeat mRNA Drives Epigenetic Silencing in Fragile X Syndrome

  2014cited by this paper
• GABAergic circuit dysfunction in the Drosophila Fragile X syndrome model.

  2014cited by this paper
• Psychiatric symptoms in boys with fragile X syndrome: a comparison with nonsyndromic autism spectrum disorder.

  2014cited by this paper
• Oxytocin-Mediated GABA Inhibition During Delivery Attenuates Autism Pathogenesis in Rodent Offspring

  2014cited by this paper
• Autism Treatment in the First Year of Life: A Pilot Study of Infant Start, a Parent-Implemented Intervention for Symptomatic Infants

  2014cited by this paper
• The Developmental Switch in GABA Polarity Is Delayed in Fragile X Mice

  2014cited by this paper
• Genetic Removal of Matrix Metalloproteinase 9 Rescues the Symptoms of Fragile X Syndrome in a Mouse Model

  2014cited by this paper
• Longitudinal Profiles of Adaptive Behavior in Fragile X Syndrome

  2014cited by this paper
• Mechanism-based treatments in neurodevelopmental disorders: fragile X syndrome.

  2014cited by this paper
• A feasibility trial of Cogmed working memory training in fragile X syndrome

  2014cited by this paper
• Fragile X Syndrome: A Review of Associated Medical Problems

  2014cited by this paper
• The fragile X syndrome–autism comorbidity: what do we really know?

  2014cited by this paper
• Fragile X mental retardation protein regulates translation by binding directly to the ribosome.

  2014cited by this paper
• Fragile X syndrome due to a missense mutation

  2014cited by this paper
• Analysis of FMRP mRNA target datasets reveals highly associated mRNAs mediated by G-quadruplex structures formed via clustered WGGA sequences.

  2014cited by this paper
• Climbing the branches of a family tree: diagnosis of fragile X syndrome.

  2014cited by this paper
• Clinical and molecular implications of mosaicism in FMR1 full mutations

  2014cited by this paper
• A comparison of family financial and employment impacts of fragile X syndrome, autism spectrum disorders, and intellectual disability.

  2014cited by this paper
• Fragile X mental retardation protein controls synaptic vesicle exocytosis by modulating N-type calcium channel density

  2014cited by this paper
• Impact of acamprosate on plasma amyloid-β precursor protein in youth: a pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker.

  2014cited by this paper
• Mouse models of the fragile X premutation and fragile X-associated tremor/ataxia syndrome

  2014cited by this paper
• Modeling family adaptation to fragile X syndrome.

  2014cited by this paper
• Effect of lovastatin on behavior in children and adults with fragile X syndrome: An open‐label study

  2014cited by this paper
• AGG interruptions and maternal age affect FMR1 CGG repeat allele stability during transmission

  2014cited by this paper
• Common variants in genes of the postsynaptic FMRP signalling pathway are risk factors for autism spectrum disorders

  2014cited by this paper
• Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers

  2014cited by this paper
• Associated features in females with an FMR1 premutation

  2014cited by this paper
• Fragile X syndrome neurobiology translates into rational therapy.

  2014cited by this paper
• Pharmacogenetic Inhibition of eIF4E-Dependent Mmp9 mRNA Translation Reverses Fragile X Syndrome-like Phenotypes

  2014cited by this paper
• Modulation of the GABAergic pathway for the treatment of fragile X syndrome

  2014cited by this paper

• La psicoterapia nella disabilità intellettiva è possibile? Uno studio esplorativo sugli effetti di un percorso di terapia cognitivo-comportamentale neuropsicologico integrata per giovani adulti con Sindrome X Fragile

  2026cites this paper
• The role of Fragile X in the control of vertebrate spinal cord networks

  2026cites this paper
• Non-Viral delivery of genome-editing tools for treatment of genetic disorders

  2026cites this paper
• Metabolic reprogramming during human neuron differentiation indicates glutaminase as a key determinant in Fragile X syndrome.

  2026cites this paper
• The enigma of nuclear FMRP: facts and myths.

  2026cites this paper
• Bioisostere-Driven Discovery of SePP: A Selenium-Containing Polypharmacological Agent Relevant to Fragile X Syndrome.

  2026cites this paper
• Alpha oscillations are dysrhythmic in Fragile X syndrome

  2026cites this paper
• Psilocybin improves novel object recognition in a rat model of Fragile X Syndrome through the modulation of the BDNF/TrkB signaling pathway.

  2026cites this paper
• Genetic diagnosis of three intellectually disabled individuals in a pedigree and insights into fragile X syndrome diagnosis

  2026influential citation
• Cell Type‐Specific mTORC1 Signaling and Translational Control in Synaptic Plasticity and Memory

  2025cites this paper
• Association of Non‐Coding Repeat Expansions with Parkinson's Disease Risk: Evidence from a UK Biobank‐Based Whole‐Genome Sequencing Study

  2025cites this paper
• Clinical, Genetic and Molecular Divergences Between Full Mutation and Premutation in Fragile X Syndrome: A Systematic Review

  2025cites this paper
• Bi-allelic variants in the ribosomal protein RPS6KC1 cause a complex neurodevelopmental disorder.

  2025cites this paper
• Harnessing the microbiota-gut–brain axis to prevent and treat pediatric neurodevelopmental disorders: translational insights and strategies

  2025cites this paper
• The downregulation of Autophagy in amygdala is sufficient to alleviate anxiety-like behaviors in Post-traumatic Stress Disorder model mice

  2025cites this paper
• Age-varying distinct neuroanatomy in young children with autism spectrum disorder and fragile X syndrome.

  2025cites this paper
• A CGG Repeat Expansion in CSNK1E Associated with Progressive Myoclonic Epilepsy with Incomplete Penetrance

  2025cites this paper
• Hyper-extralemniscal model of Fragile X syndrome.

  2025cites this paper
• Frontal cortex hyperactivation and gamma desynchrony in Fragile X syndrome: Correlates of auditory hypersensitivity

  2025cites this paper
• The association of CGG repeat length and AGG interruption patterns on FMR1 alleles with female infertility

  2025cites this paper
• Loss of FMRP in microglia promotes degeneration of parvalbumin neurons and audiogenic seizures via progranulin insufficiency

  2025cites this paper
• Estimation of the prevalence of fragile X syndrome in England from the Clinical Practice Research Datalink

  2025cites this paper
• Delayed structural maturation of inner hair cell ribbon synapses in a mouse model of fragile X syndrome

  2025cites this paper
• Enhanced accuracy and sensitivity in detecting FMR1 CGG repeats: a multicenter evaluation of a novel PCR-capillary electrophoresis assay

  2025cites this paper
• Serum Metabolic and Gut Microbiome Differences in Age-Associated Fragile X Syndrome (FXS) Pediatric Patients May Benefit Clinical Therapy Development

  2025cites this paper
• Neuropsychiatric Manifestations in a Patient Identified as a Premutation Carrier of the FMR1 Gene Linked to Fragile X Syndrome

  2025cites this paper
• Comparing loss of individual fragile X proteins suggests strong links to cellular senescence and aging

  2025cites this paper
• Aberrant Neural Entrainment to Word-Level Speech Patterns in Fragile X Syndrome: Evidence for a Statistical Learning Deficit

  2025cites this paper
• Overlapping Pathways: Autism Spectrum Disorder in Fragile X Carrier States and the Need for Greater Awareness

  2025cites this paper
• Brian Intensify: An Adaptive Machine Learning Framework for Auditory EEG Stimulation and Cognitive Enhancement in FXS

  2025cites this paper
• FMR1 Methylation Pattern and Repeat Expansion Screening in a Cohort of Boys with Autism Spectrum Disorders: Correlation of Genetic Findings with Clinical Presentations

  2025cites this paper
• Erasing “bad memories”: reversing aberrant synaptic plasticity as therapy for neurological and psychiatric disorders

  2025cites this paper
• Therapeutic Effects of Pharmacological Modulation of Serotonin Brain System in Human Patients and Animal Models of Fragile X Syndrome

  2025cites this paper
• Spontaneous distal middle cerebral artery aneurysm in a young male with full mutation of the fragile X syndrome with a high-functioning phenotype: illustrative case

  2025cites this paper
• A Case of Kabuki Make-up Syndrome Type-2 with Autism Spectrum Disorder

  2025cites this paper
• Alternative splicing in autism spectrum disorder: Recent insights from mechanisms to therapy.

  2025cites this paper
• Aberrant Short Tandem Repeats: Pathogenicity, Mechanisms, Detection, and Roles in Neuropsychiatric Disorders

  2025cites this paper
• Children With Fragile X Syndrome Display a Switch Towards Fast Fibres in Their Recruitment Strategy During Gait

  2025cites this paper
• Olfactory dysfunction and altered cortical excitability in the mouse model of Fragile X Syndrome

  2025cites this paper
• Cortical layer-specific abnormalities in auditory responses in a mouse model of Fragile X Syndrome.

  2025cites this paper
• FMR1: A Neurodevelopmental Factor Regulating Cell Metabolism in the Tumor Microenvironment

  2025cites this paper
• The yin and yang of neuronal mitophagy: physiological functions and pathological implications in neurodevelopmental disorders

  2025cites this paper
• Decomposition of phenotypic heterogeneity in autism reveals underlying genetic programs

  2025cites this paper
• Oxford Nanopore Third Generation Sequencing for Analysis of FMR1 5'UTR CGG Repeat Expansions.

  2025cites this paper
• Long Read Genome Sequencing Elucidates Diverse Functional Consequences of Structural and Repeat Variation in Autism

  2025cites this paper
• Therapeutic strategies for fragile X syndrome and implications for other gene-silencing disorders

  2025cites this paper
• Challenges faced by a sample of Middle Eastern group of FMR1 premutation mothers having children with fragile X syndrome

  2025cites this paper
• The integrated stress response in the brain: cell type-specific functions in health and neurological disorders.

  2025cites this paper
• FMR1 mutant marmosets show fragile X syndrome phenotypes.

  2025cites this paper
• Aberrant hippocampal gamma oscillations in a mouse model of fragile X syndrome: insights from in vitro slice models

  2025cites this paper
• FX ENTRAIN: scientific context, study design, and biomarker driven brain-computer interfaces in neurodevelopmental conditions

  2025cites this paper
• Prevalence of Fragile X syndrome in Georgian patients with autism spectrum disorder and/or intellectual disability: cross-sectional study and review of current approaches

  2025cites this paper
• Divergent aperiodic slope and alpha dynamics expose cortical excitability gradients in fragile X syndrome

  2025cites this paper
• Behavioral benefits of GSK-3β inhibition and state-dependent microtubule signatures in the Fmr1-KO mouse

  2025cites this paper
• Extracellular Vesicles-Dependent Secretion Regulates Intracellular CYFIP2 Protein Homeostasis in Cortical Neurons

  2025influential citation
• FMRP attenuates Tau pathology through the CDK5/p35 signaling pathway.

  2025cites this paper
• A missense variant in the KH0-domain of FMRP downregulates the protein in a patient with the clinical hallmarks of fragile X syndrome

  2025influential citation
• Relationship Between Intellectual Disability and Behavioral Comorbidity in Children With Fragile X Syndrome.

  2025cites this paper
• Non-CGG trinucleotide repeat expansions as pathogenic genetic mutations in Fragile X Syndrome

  2025cites this paper
• Fragile X mental retardation 1 gene FMR1 promotes proliferation, migration, and invasion of gastric cancer cells via c-MYC

  2025cites this paper
• From Mutations to Microbes: Investigating the Impact of the Gut Microbiome on Repeat Expansion Disorders

  2025cites this paper
• Gene Therapy for Fragile X Syndrome, Challenges, and Promises

  2025cites this paper
• ISR Modulators in Neurological Diseases

  2025cites this paper
• Mosaicism in Short Tandem Repeat Disorders: A Clinical Perspective

  2025cites this paper
• Impairment in the homeostatic recruitment of layer 5/6 neurons following whisker stimulation in Fmr1 KO mice

  2025cites this paper
• Astrocytic contribution to auditory hypersensitivity in a mouse model of fragile X syndrome

  2025cites this paper
• Engrams across diseases: Different pathologies - unifying mechanisms?

  2025cites this paper
• Auditory steady-state response deficits in Fragile X Syndrome implicate deficits in stimulus representation maintenance and GABAergic modulation

  2025cites this paper
• Altered auditory feature discrimination in a rat model of Fragile X Syndrome

  2025cites this paper
• Upregulation of FMRP Is Involved in Neuropathic Pain by Regulating GluN2B Activation in Rat Spinal Cord

  2025cites this paper
• Postnatal downregulation of Fmr1 in microglia promotes microglial reactivity and causes behavioural alterations in female mice

  2025cites this paper
• Brain Network Alterations in Fragile X Syndrome.

  2025cites this paper
• The developing visual system: A building block on the path to autism

  2025cites this paper
• Mosaic H3K9me3 at BREACHes predicts synaptic gene expression associated with fragile X syndrome cognitive severity

  2025cites this paper
• From Discovery to Innovative Translational Approaches in 80 Years of Fragile X Syndrome Research

  2025influential citation
• Beyond Repetition: The Role of Gray Zone Alleles in the Upregulation of FMR1-Binding miR-323a-3p and the Modification of BMP/SMAD-Pathway Gene Expression in Human Granulosa Cells

  2025cites this paper
• Delayed maturation of inner hair cell ribbon synapses in a mouse model of fragile X syndrome

  2025cites this paper
• Compensatory Regulation of Excitation/Inhibition Balance in the Ventral Hippocampus: Insights from Fragile X Syndrome

  2025cites this paper
• Neural Connections and Molecular Mechanisms Underlying Motor Skill Deficits in Genetic Models of Autism Spectrum Disorders.

  2025cites this paper
• A Rare Case of Female Fragile X Syndrome with Uncommon Association of Hyperglycemia and Diabetic Ketoacidosis Managed Conservatively in a low resource setting- A Case Report.

  2025cites this paper
• A Primary Care Approach to Visual Screening in Adults with Intellectual and Developmental Disabilities

  2025cites this paper
• Hippocampal-prefrontal functional neural networks in a rat model of fragile X syndrome are poorly organized with limited resiliency

  2025cites this paper
• Genetics of catatonia: a systematic review of case reports and a gene pathway analysis

  2025cites this paper
• ROC Analysis of Biomarker Combinations in Fragile X Syndrome-Specific Clinical Trials: Evaluating Treatment Efficacy via Exploratory Biomarkers

  2025cites this paper
• Atypical Retinal Ganglion Cell Function in a Mouse Model of Fragile X Syndrome

  2025cites this paper
• PQBP1-dependent alternative RNA splicing underlies high calorie diet-induced cognitive impairment

  2025cites this paper
• From Caring to Killing: A Typology of Homicides and Homicide–Suicides Perpetrated by Caregivers

  2025cites this paper
• Altered auditory feature discrimination in a rat model of Fragile X Syndrome

  2025cites this paper
• Alterations in Electroencephalography Signals in Female Fragile X Syndrome Mouse Model on a C57Bl/6J Background

  2025cites this paper
• FMRP drives mRNP targets into translationally silenced complexes.

  2025cites this paper
• 5-mC DNA methylation in neurodevelopment: from molecular mechanisms to therapeutic implications

  2025cites this paper
• Conditional deletion of TRPC1 channel modulates synaptic plasticity, long term depression, and memory extinction in Fragile X syndrome mice

  2025cites this paper
• Prevalence of NOTCH2NLC and FMR1 Repeat Expansions in Atypical Parkinsonism Compared to Asymptomatic Elderly Individuals

  2025cites this paper
• FMRP regulation of STAT3-MYC signaling is critical for adult hippocampal neurogenesis and cognitive flexibility

  2025cites this paper
• Exploring the Relationship Between Fragile X Syndrome and Autism: A Bibliometric Analysis of Global Research Trends

  2025cites this paper
• Mechanisms of genome instability from cellular folate stress.

  2025cites this paper
• Genetic Subtypes of Phelan-McDermid Syndrome Exhibit Similar Rates of Change Despite Differences in Level of Impairment in Developmental Constructs.

  2025cites this paper
• Preliminary perspectives on gene therapy in fragile X syndrome: a caregiver view

  2025cites this paper
• Exaggerated NMDA Receptor–Primed Metaplasticity via SK Channel Dysregulation in Fmr1 Knockout Mice

  2025cites this paper
• Expert consensus on classification and diagnosis of congenital orofacial cleft.

  2025cites this paper